Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 Perifosine for Treatment of Patients with Advanced Multiple Myeloma
Published in Blood Weekly, December 31st, 2009
The trial, entitled, "A Phase 3 Randomized Study to Assess the Efficacy and Safety of Perifosine Added to the Combination of Bortezomib (Velcade®) and Dexamethasone in Multiple Myeloma Patients Previously Treated with Bortezomib" is a double-blind, placebo-controlled trial comparing the efficacy and safety of perifosine vs. placebo when combined with bortezomib (Velcade®) and dexamethasone. The trial will enroll approximately 400...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-12-31)
More Articles from Blood Weekly
- Indiana University School of Medicine
IUPUI researchers tackle protein mechanisms behind limb regeneration - Mayo Clinic
Mayo Clinic Proceedings: Researchers find evidence of survival gains in bone marrow disease - Adrenal Insufficiency
New adrenal insufficiency findings from Oregon Health & Science University published - Amyotrophic Lateral Sclerosis
Researchers' work from University of Sydney focuses on amyotrophic lateral sclerosis - ARIAD Pharmaceuticals, Inc.
ARIAD Presents Positive Clinical Proof-of-Concept Data on AP24534 in Drug-Resistant Hematological Cancers at ASH Annual Meeting - Bristol-Myers Squibb Company and Pfizer
Bristol-Myers Squibb and Pfizer Announce Plans To Submit Regulatory Filing for Apixaban In Europe - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
